Abstract
6-[125I]-Iodo-2-methyl-1,4-naphtoquinol bis-(diammonium phosphate) has been prepared as a potential radiochemotherapeutic drug with a specific activity of 1·82mCi/mg; laboratory studies have shown comparable uptake and cytotoxicity for tumour cells cultured in vitro under anoxic and euoxic conditions.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have